On September 14, 2009
Why Vivus’s Qnexa Might Not Avoid the Obesity Drug Graveyard
Many have tried. None have succeeded. And now Vivus — a young Arthur of Pharmalot, if you will — believes it can pull the sword from the stone. Qnexa has twice blown through the FDA’s required “5 percent better than placebo” weight-loss standard. What could possibly go wrong? Three things.
0 Comments